Market Place
Sourcing Support
Kimera® Labs Responds to FDA Warning Letter
23 Jan 2024 //
PR NEWSWIRE
Kimera® Labs Receives FDA PhI/IIa IND Approval For Its MSC Exosomes Human Study
16 May 2023 //
PR NEWSWIRE
Kymera Therapeutics Karen Weisbach as Vice President, Jolly Bhatia
29 Jul 2021 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.